Terms: = Breast cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Diagnosis
43 results:
1. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With breast cancer.
Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
[TBL] [Abstract] [Full Text] [Related]
2. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for breast and Prostate cancer: An Episode-Based Analysis From 2015 to 2019.
Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
[TBL] [Abstract] [Full Text] [Related]
3. Annual report of the Japanese breast cancer Registry for 2019.
Miyashita M; Kumamaru H; Niikura N; Sagara Y; Konishi T; Iwamoto T; Sanuki N; Tanakura K; Nagahashi M; Hayashi N; Yoshida M; Watanabe C; Kinukawa N; Toi M; Saji S
Breast Cancer; 2024 Jan; 31(1):16-23. PubMed ID: 38044372
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer screening and its associating factors among hungarian women aged 45-65: a cross-sectional study based on the European health interview surveys from 2009 to 2019.
Pataki J; Dombrádi V; Sárváry A; Szőllősi GJ
BMC Public Health; 2023 Aug; 23(1):1679. PubMed ID: 37653363
[TBL] [Abstract] [Full Text] [Related]
5. Germline Genetic Testing After cancer diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
6. CD24-associated ceRNA network reveals prognostic biomarkers in breast carcinoma.
Yu B; Zhao Z; Chen Z; Xiang C; Wang P; Xiao B; Xia Y; Li A; Xiao T; Li H
Sci Rep; 2023 Mar; 13(1):3826. PubMed ID: 36882451
[TBL] [Abstract] [Full Text] [Related]
7. Reproductive Outcomes in Young breast cancer Survivors Treated (15-39) in Ontario, Canada.
Rushton M; Pudwell J; Wei X; Powell M; Richardson H; Velez MP
Curr Oncol; 2022 Nov; 29(11):8591-8599. PubMed ID: 36421330
[TBL] [Abstract] [Full Text] [Related]
8. Health-related quality of life among breast cancer patients in India.
Gupta N; Pandey AK; Dimri K; Jyani G; Goyal A; Prinja S
Support Care Cancer; 2022 Dec; 30(12):9983-9990. PubMed ID: 36222977
[TBL] [Abstract] [Full Text] [Related]
9. Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
Mighri N; Mejri N; Boujemaa M; Berrazega Y; Rachdi H; El Benna H; Labidi S; Benna F; Boubaker S; Boussen H; Abdelhak S; Hamdi Y
PLoS One; 2022; 17(9):e0269732. PubMed ID: 36094928
[TBL] [Abstract] [Full Text] [Related]
10. Small lesion classification on abbreviated breast MRI: training can improve diagnostic performance and inter-reader agreement.
Liu Z; Liang K; Zhang L; Lai C; Li R; Yi L; Li R; Zhang L; Long W
Eur Radiol; 2022 Aug; 32(8):5742-5751. PubMed ID: 35212772
[TBL] [Abstract] [Full Text] [Related]
11. Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer.
Wen L; Zhong G; Zhang Y; Zhong M
Bosn J Basic Med Sci; 2022 Jun; 22(3):471-480. PubMed ID: 34716699
[TBL] [Abstract] [Full Text] [Related]
12. Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
McSorley LM; Tharmabala M; Al Rahbi F; McSorley K; Chew S; Evoy D; Geraghty JG; Prichard RS; Rothwell J; McCartan DP; McDermott EW; Keane M; Kennedy MJ; O'Reilly S; Millen SJ; Crown JP; Smyth LM; Kelly CM; Quinn CM; Walshe JM
Breast Cancer Res Treat; 2021 Aug; 188(3):789-798. PubMed ID: 33835293
[TBL] [Abstract] [Full Text] [Related]
13. Absence of detectable effect of radiotherapy and chemotherapy for breast cancer on the presence of low voltage areas in patients receiving left atrial catheter ablation.
Hashiguchi N; Schenker N; Rottner L; Reißmann B; Rillig A; Maurer T; Lemes C; Kuck KH; Ouyang F; Mathew S
Acta Cardiol; 2021 Dec; 76(10):1061-1068. PubMed ID: 32914694
[TBL] [Abstract] [Full Text] [Related]
14. Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer.
Aghdam N; McGunigal M; Wang H; Repka MC; Mete M; Fernandez S; Dash C; Al-Refaie WB; Unger KR
Cancer Med; 2020 Aug; 9(15):5362-5380. PubMed ID: 32511873
[TBL] [Abstract] [Full Text] [Related]
15. Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups.
Killelea BK; Herrin J; Soulos PR; Pollack CE; Forman HP; Yu J; Xu X; Tannenbaum S; Wang SY; Gross CP
Breast Cancer; 2020 May; 27(3):381-388. PubMed ID: 31792804
[TBL] [Abstract] [Full Text] [Related]
16. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
Majid S; Rydén L; Manjer J
BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
[TBL] [Abstract] [Full Text] [Related]
17. Bcl-3 promotes proliferation and chemosensitivity in BL1 subtype of TNBC cells.
Huo J; Chen X; Zhang H; Hu Y; Jiang Y; Liu S; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1141-1149. PubMed ID: 30289427
[TBL] [Abstract] [Full Text] [Related]
18. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.
Derks-Smeets IAP; Schrijver LH; de Die-Smulders CEM; Tjan-Heijnen VCG; van Golde RJT; Smits LJ; Caanen B; van Asperen CJ; Ausems M; Collée M; van Engelen K; Kets CM; van der Kolk L; Oosterwijk JC; van Os TAM; ; Rookus MA; van Leeuwen FE; Gómez García EB
Br J Cancer; 2018 May; 119(3):357-363. PubMed ID: 29937543
[TBL] [Abstract] [Full Text] [Related]
19. breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11.
Cubasch H; Dickens C; Joffe M; Duarte R; Murugan N; Tsai Chih M; Moodley K; Sharma V; Ayeni O; Jacobson JS; Neugut AI; McCormack V; Ruff P
Cancer Epidemiol; 2018 Feb; 52():120-127. PubMed ID: 29306221
[TBL] [Abstract] [Full Text] [Related]
20. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Angelini G; Marini C; Iacconi C; Mazzotta D; Moretti M; Picano E; Morganti R
Clin Imaging; 2018; 49():12-16. PubMed ID: 29120811
[TBL] [Abstract] [Full Text] [Related]
[Next]
